The potential of PARP as a therapeutic target across pediatric solid malignancies.
Saved in:
| Title: | The potential of PARP as a therapeutic target across pediatric solid malignancies. |
|---|---|
| Authors: | Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koetsier J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Handel K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ober K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Essing A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Kool M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Pfister S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. |
| Source: | BMC cancer [BMC Cancer] 2023 Apr 05; Vol. 23 (1), pp. 310. Date of Electronic Publication: 2023 Apr 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37020198 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The potential of PARP as a therapeutic target across pediatric solid malignancies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Keller+KM%22">Keller KM</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Koetsier+J%22">Koetsier J</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schild+L%22">Schild L</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Amo-Addae+V%22">Amo-Addae V</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Eising+S%22">Eising S</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Handel+K%22">van den Handel K</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ober+K%22">Ober K</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Koopmans+B%22">Koopmans B</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Essing+A%22">Essing A</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Boogaard+ML%22">van den Boogaard ML</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Langenberg+KPS%22">Langenberg KPS</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Jäger+N%22">Jäger N</searchLink>; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kool+M%22">Kool M</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Pfister+S%22">Pfister S</searchLink>; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dolman+MEM%22">Dolman MEM</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Molenaar+JJ%22">Molenaar JJ</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl.<br /><searchLink fieldCode="AU" term="%22van+Hooff+SR%22">van Hooff SR</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2023 Apr 05; Vol. 23 (1), pp. 310. <i>Date of Electronic Publication: </i>2023 Apr 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37020198 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-022-10319-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 310 Titles: – TitleFull: The potential of PARP as a therapeutic target across pediatric solid malignancies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Keller KM – PersonEntity: Name: NameFull: Koetsier J – PersonEntity: Name: NameFull: Schild L – PersonEntity: Name: NameFull: Amo-Addae V – PersonEntity: Name: NameFull: Eising S – PersonEntity: Name: NameFull: van den Handel K – PersonEntity: Name: NameFull: Ober K – PersonEntity: Name: NameFull: Koopmans B – PersonEntity: Name: NameFull: Essing A – PersonEntity: Name: NameFull: van den Boogaard ML – PersonEntity: Name: NameFull: Langenberg KPS – PersonEntity: Name: NameFull: Jäger N – PersonEntity: Name: NameFull: Kool M – PersonEntity: Name: NameFull: Pfister S – PersonEntity: Name: NameFull: Dolman MEM – PersonEntity: Name: NameFull: Molenaar JJ – PersonEntity: Name: NameFull: van Hooff SR IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 04 Text: 2023 Apr 05 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 23 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |